Report sees cardiac ultrasound growth
A new report published by Frost & Sullivan of Mountain View,CA, predicts that ultrasound's share of the cardiac imaging marketwill grow in coming years, while that of x-ray and nuclear medicinedeclines. The publication claims that the worldwide
A new report published by Frost & Sullivan of Mountain View,CA, predicts that ultrasound's share of the cardiac imaging marketwill grow in coming years, while that of x-ray and nuclear medicinedeclines. The publication claims that the worldwide market forcardiac medical imaging equipment will hit $2.09 billion in revenuesin 2002, compared with $1.66 billion last year: a 3% annual growthrate.
The report, entitled World Cardiac Diagnostic Imaging EquipmentMarket, states that echocardiography's market share in cardiacimaging will rise from 38% in 1995 to 41% in 2002, while cardiac-basedx-ray will fall from 43% to 42% and nuclear medicine will declinefrom 13% to 12% in the same period. CT had 4% of the cardiac imagingmarket in 1995 and MRI had 2%.
Frost & Sullivan researchers believe that the move towardless invasive procedures will benefit other modalities at theexpense of x-ray catheterization, with echocardiography and cardiacMRI being major beneficiaries.
Prices have eroded 25% over the last three years in some cardiacimaging segments, according to the report.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
